ONCO Hisse Senedi Fiyat Grafiği
ONCO Finansal
Onconetix Inc
$0.95
-11.52%
$-0.12
Kapanışta: Jul 02, 16:00:00 GMT-4
$0.94
-1.62%
$-0.01
Sonrası Piyasa: Jul 02, 20:00:00 GMT-4
Geri
Onconetix Inc (ONCO) Finansal
Önemli İstatistikler
Önceki Kapanış
$1.08
Açılış fiyatı
$1.1
Günün Aralığı
$0.93 - $1.1
52 haftalık aralık
$0.91 - $361.5
İşlem hacmi
386.5K
Ort.Hacim
857.7K
Dividend yield
--
EPS (TTM)
-219.70
Piyasa Değeri
$1.0M
ONCO nedir?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio and currently employs 2 full-time employees. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
